Is ATYR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ATYR. It does not provide personalized investment advice.

ATYR (aTyr Pharma, Inc. Common Stock) Stock Analysis - Financials

aTyr Pharma, Inc. Common Stock (ATYR) is a publicly traded Healthcare sector company. As of July 15, 2026, ATYR trades at $0.54 with a market cap of $49.43M and a P/E ratio of -0.63. ATYR moved +12.47% today. Year to date, ATYR is -37.94%; over the trailing twelve months it is -91.21%. Its 52-week range spans $0.40 to $7.29. Analyst consensus is buy with an average price target of $3.13. Rallies surfaces ATYR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ATYR's key financials?

ATYR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ATYR recently traded at $0.54. Market cap is $49.43M. P/E ratio is -0.63. Revenue is $190.00K.

ATYR Key Metrics

Key financial metrics for ATYR
Metric	Value
Price	$0.54
Market Cap	$49.43M
P/E Ratio	-0.63
EPS	$-0.80
Dividend Yield	0.00%
52-Week High	$7.29
52-Week Low	$0.40
Volume	5.09M
Avg Volume	0
Revenue (TTM)	$190.00K
Net Income	$-74.12M
Gross Margin	0.00%

ATYR Analyst Consensus

6 analysts cover ATYR: 0 strong buy, 2 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.13.

Common questions about ATYR

What are ATYR's key financials?: ATYR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ATYR recently traded at $0.54. Market cap is $49.43M. P/E ratio is -0.63. Revenue is $190.00K.
Is ATYR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ATYR. It does not provide personalized investment advice.